{
    "nct_id": "NCT03128866",
    "official_title": "Reducing Blood Loss in Hemipelvectomy Surgery With the Use Tranexamic Acid (TXA)",
    "inclusion_criteria": "* Both pediatric and adult patients can be eligible to participate\n* Cognitively impaired and non-English speakers can be eligible to participate.\n* Both male and female patients must have a pelvic tumor and are scheduled to have surgery at University of Texas (UT) Monroe Dunaway (MD) Anderson Cancer center that require hemipelvectomy, resulting in pelvic ring disruption\nHealthy volunteers allowed",
    "exclusion_criteria": "* Patient with a history of genetic prothrombotic state\n* Patient with a history of thromboembolic disease to include pulmonary embolus or other extremity deep venous thrombosis\n* Patients with thrombosis of the planned site of resection will not be excluded if the thrombus is caused directly by tumor burden or outflow obstruction\n* Female patients will not be eligible for this study if she is either pregnant or nursing at the time of enrollment\n* Patients will not be eligible if they have a history of color vision defects\n* Patients will not be eligible if they have a history of retinal vein or artery occlusion\n* Patients will not be eligible if they have a history of intracranial hemorrhage in past 6 months\n* Patients will not be eligible if they have a history of hypersensitivity to tranexamic acid\n* Patients will not be eligible if they present with moderate to severe decrease in creatinine clearance (estimated glomerular filtration rate [eGFR] < 45 mL/min/1.73m2)\n* Patients will not be eligible if they present or have a history of seizure disorder",
    "miscellaneous_criteria": ""
}